How Complications Impact Type 2 Diabetic Costs?

Main Category: Diabetes
Article Date: 13 May 2009 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:1 star

1 (1 votes)


The study populations were 1530 outpatients and 524 inpatients from clinics or wards of a total of 20 hospitals.

The purpose of this study was to evaluate the direct medical costs of type 2 diabetes mellitus incurred by complications, and to determine the economic impact of complications on type 2 diabetic patients.

Complications caused extra 70% medical cost on diabetic patients. A recent study, "How Do Type 2 Diabetes Mellitus-Related Chronic Complications Impact Direct Medical Cost in Four Major Cities of Urban China?", published in Value in Health, indicated that patients simultaneously suffering micro and macrovascular complications had highest direct medical cost than the others. More complications a patient has, a higher direct medical cost he or she need to pay.

The estimates of economic burden of type 2 diabetes in China will be discussed in Value in Health, the official journal of the International Society for Pharmacoeconomics and outcomes Research.

The study was co-authored by Weibing Wang, Chaowei Fu, Changyu Pan, et al, and corresponding to Dr. Xu, the professor of School of Public Health at Fudan University. Says Dr. Xu, while the high economic burden raised by diabetes and its complications challenges the Chinese health care system and implicates an urgent need of intervention to prevent the development of long-term complications among the diabetic population.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research and help health care leaders to make decisions that are solidly evidence-based. The journal is published bi-monthly and has a regular readership of over 4,000 clinicians, decision-makers, and researchers worldwide.

ISPOR is a nonprofit, international organization that strives to translate pharmacoeconomics and outcomes research into practice to ensure that society allocates scarce health care resources wisely, fairly, and efficiently.

Source
ISPOR

Article adapted by Medical News Today from original press release.
Visit our diabetes section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
ISPOR. "How Complications Impact Type 2 Diabetic Costs?." Medical News Today. MediLexicon, Intl., 13 May. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/149884.php>

APA
ISPOR. (2009, May 13). "How Complications Impact Type 2 Diabetic Costs?." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/149884.php.

Please note: If no author information is provided, the source is cited instead.


Diabetes

What is Diabetes?

Diabetes (diabetes mellitus) is classed as a metabolism disorder. Metabolism refers to the way our bodies use digested food for energy and growth. Most of what we eat is broken down into glucose. Glucose is a form of sugar in the blood... Read more...

Most Popular Articles



Follow Our Diabetes News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Diabetes Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »